fda 503a bulks list peptides bpc-157 Exciting news for coming out of today's committee hearing! The Pharmacy Compounding Advisory Committee voted 8-6 to recommend adding BPC- 157 to the for use in compounding for HIMS is up nearly 8%

HIMS is up nearly 8% after FDA advisers voted to recommend adding BPC 157 to the 503A Bulks List. A major win for the peptide market. Big decisions could be coming for peptide compounding. Over the next few days, the FDA's Pharmacy Compounding Advisory Committee will discuss several peptides, including BPC 157, and whether they should be considered for FDA Advisers Vote to Ease Restrictions on BPC 157, TB 500, and Other Novel Peptides Glitchwire The biggest regulatory moment for peptides in 2026 happens this week. On July 23 and 24, the FDA's Pharmacy Compounding Advisory Committee meets to vote on whether BPC 157, TB 500, KPV, MOTS c, DSIP

SKU: 41771828991 · From www.asociacionchamorro.org